ORIGINAL ARTICLE: Clinical Endoscopy

Size: px
Start display at page:

Download "ORIGINAL ARTICLE: Clinical Endoscopy"

Transcription

1 ORIGINAL ARTICLE: Clinical Endoscopy Impact of experience with a retrograde-viewing device on adenoma detection rates and withdrawal times during colonoscopy: the Third Eye Retroscope study group Daniel C. DeMarco, MD, Elizabeth Odstrcil, MD, Luis F. Lara, MD, David Bass, MD, Chase Herdman, MD, Timothy Kinney, MD, Kapil Gupta, MD, Leon Wolf, MD, Thomas Dewar, MD, Thomas M. Deas, MD, Manoj K. Mehta, MD, M. Badar Anwer, MD, Randall Pellish, MD, J. Kent Hamilton, MD, Daniel Polter, MD, K. Gautham Reddy, MD, Ira Hanan, MD Dallas, North Richland Hills, Fort Worth, Texas, Minneapolis, Minnesota, Evanston, Chicago, Illinios, Celebration, Florida, Worcester, Massachusetts, USA Background: Colonoscopy has been adopted as the preferred method to screen for colorectal neoplasia in the United States. However, lesions can be missed because of numerous factors, including location on the proximal aspect of folds or flexures, where they may be difficult to detect with the forward-viewing colonoscope. The Third Eye Retroscope (TER) is a disposable device that is passed through the instrument channel of a standard colonoscope to provide a retrograde view that complements the forward view of the colonoscope during withdrawal. Objective: To evaluate whether experience with the TER affects polyp detection rates and procedure times in experienced endoscopists who had not previously used the equipment. Design, Setting, Patients: This was an open-label, prospective, multicenter study at 9 U.S. sites, involving 298 patients presenting for colonoscopy, evaluating the use of the TER in combination with a standard colonoscope. Interventions: After cecal intubation, the TER was inserted through the instrument channel of the colonoscope. During withdrawal, the forward and retrograde video images were observed simultaneously on a wide-screen monitor. Main Outcome Measurements: Primary outcome measures were the number and size of adenomas and all polyps detected with the standard colonoscope and with the colonoscope combined with the TER. Secondary outcome measures were withdrawal phase time and total procedure time. Each endoscopist examined 20 subjects, divided into quartiles according to the order of their procedures, and results were compared among quartiles. Results: Overall, 182 polyps were detected with the colonoscope and 27 additional polyps with the TER, a 14.8% increase (P.001). A total of 100 adenomas were detected with the colonoscope and 16 more with the TER, a 16.0% increase (P.001). For procedures performed after each endoscopist had completed 15 procedures while using the TER, the mean additional detection rates with the TER were 17.0% for all polyps (P.001) and 25.0% for adenomas (P.001). For lesions 6 mm or larger, the overall additional detection rates with the TER for all polyps and for adenomas were 23.2% and 24.3%, respectively. For lesions 10 mm or larger, the overall additional detection rates with the TER for all polyps and for adenomas were 22.6% and 19.0%, respectively. The mean withdrawal times in the first and fourth quartiles were 10.6 and 9.2 minutes, respectively (P.044). Limitations: There was no randomization or separate control group. The endoscopists judged whether each lesion could have been detected with the colonscope alone by using their standard technique. Conclusions: Polyp detection rates improved significantly with the TER, especially after 15 procedures, when the mean additional detection rate for adenomas was 25.0%. Additional detection rates with the TER for medium-size and large adenomas were greater than for smaller lesions. These results suggest that, compared with a colonoscope alone, a retrograde-viewing device can increase detection rates for clinically significant adenomas without detriment to procedure time or procedure complications. (Clinical trial registration number: NCT ) (Gastrointest Endosc 2010;71: ) 542 GASTROINTESTINAL ENDOSCOPY Volume 71, No. 3 :

2 DeMarco et al Impact of experience with a retrograde-viewing device on adenoma detection rates during colonoscopy Colorectal cancer is the second leading cause of cancer death in the United States. 1 Current strategies for reducing the toll from colorectal cancer focus on early detection and removal of potential precancerous lesions. Colonoscopy is currently regarded as the criterion standard for the detection of polyps and cancers in the colon and is the preferred method of screening for colorectal cancer in the United States. 2-6 However, evidence shows that polyps and other lesions can be missed during colonoscopy, 7-16 at least in part because of location on the proximal aspect of flexures, rectal valves, or haustral folds, where they can be difficult to see with the forwardviewing colonoscope. 13 Therefore, detection rates might be enhanced by an increased ability to visualize areas behind flexures and folds. Capsule Summary What is already known on this topic In screening for colorectal neoplasia, the standard forward-viewing colonoscope may not detect lesions on the proximal aspect of folds or flexures. What this study adds to our knowledge In a prospective, multicenter study, detection of polyps increased 14.8% and detection of adenomas increased 16% with the addition of a retrograde-viewing device compared with the standard colonoscope alone. After each endoscopist had completed 15 procedures with the device, detection rates for polyps and adenomas increased to 17% and 25%, respectively. BACKGROUND The Third Eye Retroscope (TER) (Avantis Medical Systems, Inc, Sunnyvale, Calif) is a disposable auxiliary imaging device that is inserted through the instrument channel of a standard colonoscope to provide a retrograde view of the colon during the withdrawal phase of a colonoscopy After the colonoscope has been advanced to the cecum in the usual manner, the TER is inserted through the instrument channel. As it emerges from the distal tip of the colonoscope, the TER automatically bends 180 degrees to form a J shape (Fig. 1) so that its sensor and integrated light source are directed back toward the tip of the colonoscope. The device is then withdrawn together with the Abbreviation: TER, Third Eye Retroscope. DISCLOSURE: The following author disclosed a financial relationship relevant to this publication: D.C. DeMarco: Consultant for Spirus Medical. All other authors disclosed no financial relationships relevant to this publication. Copyright 2010 by the American Society for Gastrointestinal Endoscopy /$36.00 doi: /j.gie Received September 4, Accepted December 4, Current affiliations: Baylor University Medical Center (D.C.D, E.O., L.F.L., J.K.H., D.P.), Dallas, Texas, North Hills Hospital (D.B.), North Richland Hills, Texas, S.W. Fort Worth Endoscopy Center (C.H. T.D., T.M.D.), Fort Worth, Texas, Hennepin County Medical Center (T.K., K.G.), Minneapolis, Minnesota, University of Texas Southwestern (L.W.), Dallas, Texas, NorthShore University HealthSystem (M.K.M.), Evanston, Illinois, Florida Hospital (M.B.A.), Celebration, Florida, University of Massachusetts (R.P.), Worcester, Massachusetts, University of Chicago (K.G.R., I.H.), Chicago, Illinois. Reprint requests: Daniel C. DeMarco, MD, Baylor University Medical Center, Digestive Health Associates of Texas, 712 North Washington, Suite 200, Dallas, TX If you would like to chat with an author of this article, you may contact Dr. DeMarco at DanielD@BaylorHealth.edu. colonoscope, thus providing a continuous retrograde view to complement the forward view of the colonoscope. Previous studies showed that the TER can increase detection rates for adenomas and other polyps. 18,19 Preliminary data also suggested that experience with the TER increases polyp detection rates and procedure efficiency. This study was designed to evaluate whether there is a learning curve for the TER in terms of both efficacy for polyp detection and procedure time. METHODS Fifteen experienced endoscopists at 9 U.S. sites participated in an open-label, prospective study to determine polyp detection rates and procedure time while performing colonoscopy by using a standard colonoscope (CF- Q160AL, CF-Q180AL, or CF-H180AL; Olympus America, Inc, Center Valley, Pa) with the addition of the TER, a retrograde-viewing auxiliary imaging device, during the withdrawal phase. The participating endoscopists had no previous experience with the TER other than a training session with an anatomical model. Subjects were invited to participate in the study if they were undergoing colonoscopy for colorectal neoplasia screening, for polyp surveillance, or for diagnostic workup (including anemia, abdominal pain, abnormal imaging) and if they were able to understand and provide written consent for the procedure. Exclusion criteria included history of colon resection, known inflammatory bowel disease, polyposis syndrome, radiation therapy to abdomen or pelvis, suspicion of chronic stricture potentially precluding complete colonoscopy, presence of diverticulitis or toxic megacolon, and concurrent enrollment in another clinical investigation. The study was approved by the institutional review board of each participating institution, and all patients signed an informed consent. Between January and June Volume 71, No. 3 : 2010 GASTROINTESTINAL ENDOSCOPY 543

3 Impact of experience with a retrograde-viewing device on adenoma detection rates during colonoscopy DeMarco et al Figure 1. After insertion through the instrument channel, the TER assumes a J shape so that its sensor and light source are directed back toward the tip of the colonoscope, providing a retrograde view to complement the forward view of the colonoscope. 2009, subjects were enrolled in sequence until each endoscopist had completed 20 procedures. Because the TER reduces suction capacity approximately 50% when it is in the channel, endoscopists were advised to lavage and suction any residual stool and pools of fluid during colonoscope insertion. The Ottawa Bowel Preparation Quality Scale 20 was used to grade the bowel preparation. If bowel preparation was deemed to be of poor quality and if the endoscopist was unable to cleanse the bowel adequately to perform a high-quality examination, the patient was excluded from the study and the TER was not used. During each procedure, the colonoscope was advanced to the cecum in the usual manner and its position was documented with photographs of the ileocecal valve, appendiceal orifice, or terminal ileum. Polyps that were found during colonoscope insertion were immediately removed and counted as having been found with the colonoscope. After water irrigation of the instrument channel of the colonoscope, the TER was inserted through the channel, much as one would insert a polypectomy snare or biopsy forceps. During withdrawal, the forward and retrograde video images were observed simultaneously side by side on a wide-screen monitor (Fig. 2). When necessary, the colonoscope water jet was used to clean the lens of the TER. When a polyp was seen, the endoscopist indicated whether it could have been seen with the colonoscope alone by using a routine degree of deflection of the tip of the colonoscope or whether it was found only because it was detected with the TER (Fig. 3). When a polyp was seen both with the colonoscope and the TER, the colonoscope was credited with finding it. For each polyp, the endoscopist indicated its size, its distance from the anal verge, and the segment of the colon in which it was found. When a polyp was seen during withdrawal, the TER was removed while maintaining the colonoscope in place. The polyp was then removed by using the tip of the colonoscope or the instrument (snare or biopsy forceps). Because each polyp was removed at the time that it was found, there was no possibility that a lesion could be counted twice. Total procedure time started with colonoscope insertion and ended when the colonoscope was withdrawn past the anal verge. Withdrawal time began when the endoscopist began to withdraw the colonoscope and TER together through the colon and ended when both were withdrawn through the anal verge. Any pauses for polypectomies, biopsies, or extensive bowel cleansing were subtracted so that the withdrawal time would represent the time that was devoted to examining the colon mucosa. A research assistant was present during the procedure to record findings and procedure times as directed by the endoscopist. Primary outcome measures were the number and size of the polyps detected with the colonoscope, and the number and size of the additional polyps that were found only because they were first detected with the TER. Secondary outcome measures were the withdrawal phase time and total procedure time. Statistical analysis The 20 subjects who were enrolled by each endoscopist were divided into quartiles, ie, the first 5 constituted the first quartile, the second 5 the second quartile, and so on. The learning curve was evaluated by comparing results among quartiles. The exact binomial test was used to determine the significance of the increased detection rates by using the TER. Differences in withdrawal times, total procedure times, and the size of polyps detected with the colonoscope and with the TER were evaluated by using analysis of variance. Differences in polyp detection between the left and right side of the colon were determined by using the Fisher exact test. For statistical purposes, the numbers of polyps were analyzed independently of whether a patient had more than 1 polyp detected. No corrections were made for the multiplicity of tests performed. RESULTS Of the 328 subjects who were enrolled, 30 (9.1%) were withdrawn per protocol for inadequate bowel preparation (n 15), inability to reach the cecum (n 9), previously unrecognized diseases in which use of the TER was considered by the endoscopists to be a potential risk factor (colitis, polyposis, severe diverticulosis; n 3), technical error (incorrect cap placed on the colonoscope; n 1), and protocol violation (n 2). Of the 298 subjects who completed the study, 144 (48.3%) were men and 154 (51.7%) were women, and their mean age was 56.8 years (standard deviation 11.3; range years). The indications were screening in GASTROINTESTINAL ENDOSCOPY Volume 71, No. 3 :

4 DeMarco et al Impact of experience with a retrograde-viewing device on adenoma detection rates during colonoscopy Figure 2. A, The forward view of the colonoscope is displayed on the left side of the split-screen monitor. B, The retrograde view on the right side of the display shows the tip of the colonoscope along with the proximal aspect of the haustral folds. Figure 3. Although this polyp was not seen on forward view on the left, it was clearly visible in the retrograde view on the right. (55.0%) subjects, polyp surveillance in 62 (20.8%), and diagnostic in 72 (24.2%). In the 298 subjects, 182 polyps were detected with the colonoscope. An additional 27 polyps were detected with the TER, a 14.8% increase (P.001). Of the polyps found with the colonoscope, 100 were adenomas. An additional 16 adenomas were detected with the TER, a 16.0% increase (P.001) (Table 1). For all polyps, the additional detection rates for the TER were 17.8% in the first quartile and 17.0% in the fourth (P.84). For adenomas, the additional detection rates for the TER increased from 15.4% in the first quartile to 25.0% in the fourth (P.48) (Table 1). For individual investigators, the additional detection rates for all polyps with the TER ranged from 0.0% to 33.3% overall and from 0.0% to 66.7% in the fourth quartile. The individual additional detection rates for adenomas with the TER ranged from 0.0% to 100.0% overall and from 0.0% to 66.7% in the fourth quartile. The mean estimated size of all polyps detected with the TER was 6.5 mm (range 2 13 mm) compared with 5.5 mm (range 1 40 mm) for those detected with the colonoscope alone (P.37). The TER allowed detection of 23.2% additional polyps 6 mm or larger (P.001) and 22.6% additional polyps 10 mm or larger (P.001) (Table 2). The mean estimated size of adenomas detected with the TER was 6.8 mm (range 2 13 mm) compared with 6.5 mm (range 1 40 mm) for adenomas found with the colonoscope (P.87). The TER allowed detection of 24.3% additional adenomas 6 mm or larger (P.001) and 19.0% additional adenomas 10 mm or larger (P.001) (Table 2). Of the total of 182 polyps seen with the colonoscope, 80 were in the right side of the colon (cecum to transverse colon) and 102 were in the left side of the colon (splenic flexure to rectum). The additional detection rates for all polyps with the TER were similar in the 2 sides of the colon at 14.7% in the left side of the colon and 15.0% in the right side of the colon (P.88). For adenomas, the Volume 71, No. 3 : 2010 GASTROINTESTINAL ENDOSCOPY 545

5 Impact of experience with a retrograde-viewing device on adenoma detection rates during colonoscopy DeMarco et al TABLE 1. Additional detection with the Third Eye Retroscope of all polyps and adenomas by quartile Quartile All polyps with COLO Additional polyps with TER % Additional polyps with TER Adenomas with COLO Additional adenomas with TER % Additional adenomas with TER Total COLO, Colonoscope; TER, Third Eye Retroscope. TABLE 2. Additional detection with the Third Eye Retroscope of all polyps and adenomas by size All polyps Adenomas Any size >6mm >10 mm Any size >6mm >10 mm No. detected with standard COLO No. additional detected with TER % additional detected with TER P value COLO, Colonoscope; TER, Third Eye Retroscope. TABLE 3. Location of all polyps and adenomas by segment of colon All polyps Adenomas Segment of colon Detected with COLO Detected with TER Total Detected with COLO Detected with TER Total Cecum Ascending colon Hepatic flexure Transverse colon Splenic flexure Descending colon Sigmoid colon Rectum Total COLO, Colonoscope; TER, Third Eye Retroscope. additional detection rates for the TER were 21.4% in the left side of the colon and 12.1% in the right side of the colon (P.28) (Tables 3 and 4). Overall detection rates for all polyps were 0.61 per patient with the colonoscope alone and 0.70 per patient with the colonoscope and TER. Overall detection rates for adenomas were 0.34 per patient with the colonoscope alone and 0.39 per patient with the colonoscope and TER. In 27 subjects (9.1%), at least 1 additional polyp was found with the TER, and in 10 subjects (3.4%), the polyp detected with the TER was the only one found. Mean withdrawal times in the first and fourth quartiles were 10.6 and 9.2 minutes, respectively (P.044). Total 546 GASTROINTESTINAL ENDOSCOPY Volume 71, No. 3 :

6 DeMarco et al Impact of experience with a retrograde-viewing device on adenoma detection rates during colonoscopy TABLE 4. Additional detection with the Third Eye Retroscope of all polyps and adenomas in the left or right side of the colon All polyps Adenomas Entire colon Right colon Left colon Entire colon Right colon Left colon No. detected with standard COLO No. additional detected with TER % additional detected with TER P value COLO, Colonoscope; TER, Third Eye Retroscope. TABLE 5. Withdrawal time and total procedure time by quartile Quartile procedure times in the first and fourth quartiles were 25.8 and 22.6 minutes, respectively (P.046) (Table 5). No colon malignancies were diagnosed. There were no device-related adverse events and no complications such as perforation, bleeding, and postprocedural hospital admission. DISCUSSION Mean (SD) withdrawal time (min) Mean (SD) total procedure time (min) (4.8) 25.8 (9.9) (4.1) 24.6 (9.7) (3.9) 26.1 (11.3) (3.4) 22.6 (4.8) Total 9.9 (4.1) 24.7 (9.7) SD, Standard deviation. Colonoscopy is the best available method for evaluating the colon because of its diagnostic and therapeutic capabilities, but extensive research has demonstrated that significant lesions can be missed during standard colonoscopy procedures. Rex et al 8 performed same-day, back-to-back (or tandem) colonoscopies on 183 patients and reported an overall adenoma miss rate of 24% (range 17%-48%). In a metaanalysis of 6 studies in which patients had undergone 2 same-day colonoscopies, Van Rijn et al 9 reported a 22% miss rate for polyps of any size. More recently, Heresbach et al 10 performed tandem colonoscopies in 286 patients and reported miss rates during the first examination of 28% for all polyps and 20% for adenomas. When compared with CT colonography, Pickhardt et al 13 found that colonoscopy had a miss rate of 12% for polyps 10 mm or larger. Pabby et al 14 determined that 23% of patients in whom colon cancer developed were diagnosed within 30 months of a previous colonoscopy during which no lesion had been found in that area of the colon. Postic et al 15 compared resected colon specimens with the results of colonoscopies performed within 5 months of surgery and found that 23.3% of the lesions in the specimens had been missed during colonoscopy, including 2 cancers measuring greater than 1.0 cm. Factors contributing to colonoscopy miss rates include poor bowel preparation, performing a rapid withdrawal, and inability to visualize some sections of the colon wall. 13 Although each of these factors is important, it is clear that some polyps are missed because they are located on the proximal aspect of haustral folds and flexures where they can be hidden from the forward view of the colonoscope despite the best efforts to improve colon visualization. This is supported by Pickhardt et al, 13 who mapped locations of nonrectal neoplasms that were detected by CT colonography but were missed by colonoscopy and found that 67% of missed lesions were on the proximal aspect of folds. The TER was designed to improve polyp detection by providing a retrograde view of the colon that reveals the areas behind haustral folds, rectal valves, flexures, and the ileocecal valve (Fig. 4). The potential effectiveness of the TER was first demonstrated in a randomized, controlled preclinical study using anatomical models 17 in which a prototype TER allowed endoscopists to detect 81% of simulated polyps located behind haustral folds compared with 12% when using the colonoscope alone. In a first human use pilot study of 24 patients, Triadafilopoulos and Li 18 found the TER allowed detection of 11.8% additional polyps compared with the colonoscope alone. Waye et al 19 examined 249 subjects with the TER in conjunction with a standard colonoscope and found additional detection rates with the TER of 13.2% for all polyps and 11.0% for adenomas. For adenomas 6 mm or larger, the additional detection rate with the TER was 25.0% and for adenomas 10 mm or larger, it was 33.3%. Volume 71, No. 3 : 2010 GASTROINTESTINAL ENDOSCOPY 547

7 Impact of experience with a retrograde-viewing device on adenoma detection rates during colonoscopy DeMarco et al Figure 4. Typical forward view of the hepatic flexure on the left, and on the right a double barrel retrograde view showing the lumens of the ascending and transverse colon. The current study was designed to determine the amount of experience required to achieve maximal proficiency with the TER. We found that even during their initial 5 procedures using the TER, endoscopists who had no previous experience with the device could detect a mean of 15.4% additional adenomas compared with the standard colonoscope. In the last quartile, after they had completed 15 procedures, their mean additional adenoma detection rate with the TER was 25.0%. Although this increase was not statistically significant, it suggests a trend toward improvement with greater experience. The variation in the results among the endoscopists suggests that they learned the basic mechanical skills after only a few procedures, but that they required varying amounts of experience to develop optimal technique. The additional polyps detected behind folds with the TER varied in size, as did the polyps found with the colonoscope. It is possible that a smaller polyp that was missed with the colonoscope because it was hidden behind a fold would grow large enough to be seen with the colonoscope at a subsequent surveillance examination. However, even if the patient were fully compliant with recommended surveillance intervals, 10 to 15 years might elapse before the lesion could be detected and removed with the colonoscope. Moreover, a subset analysis of our data showed that the TER was able to detect 19.0% additional adenomas that were at least 1 cm in diameter, lesions that most would agree are high risk and should be removed as soon as possible. The mean withdrawal time in the study was longer than the 6- to 10-minute (exclusive of time for biopsy and polypectomy) minimum proposed as a quality measure for colonoscopy, 2 and although it decreased with experience, the change was not statistically significant. Although previous colonoscope withdrawal times were not investigated for the endoscopists, it is possible that use of the TER or awareness of participation in a study might have increased their withdrawal times. Although increased withdrawal time by itself could improve detection rates with the colonoscope, the detection rates were further enhanced by use of the TER. The additional detection rate with the TER for adenomas in the left side of the colon was nonsignificantly higher than that in the right side of the colon, a trend that differs from a previous study of the TER. 19 The polyps that were detected with TER were located on the proximal aspect of haustral folds. Some were very near the edge of the fold, whereas others were farther back from the edge. Still others were located in rather deep pockets behind folds, where they would have been difficult to detect with the colonoscope even if the endoscopist were extremely conscientious and spent the time required to flatten every fold in 4 quadrants with the tip of the colonoscope. Whenever polyps were detected during withdrawal, the endoscopists noted landmarks that could assist in locating the lesions and then removed the TER to allow insertion of the polypectomy snare or biopsy forceps. As they flattened the folds with the tip of the colonoscope to remove the polyps, the endoscopists were free of any impairment that the TER might have caused. This provided them with a second opportunity to determine whether they could have detected the polyp with the colonoscope alone by using their standard technique. Overall adenoma detection rates were 0.34 per patient with the colonoscope alone and 0.39 per patient with the colonoscope and TER. These rates are within the range reported in previous studies However, several factors might have contributed to lowering the overall adenoma detection rate in this study, including the relatively equal distribution by sex (many studies involve predominantly male subjects who generally have more polyps than women) and a lower average subject age. The subjects in this study also had a broad spectrum of indications, with fewer surveillance and diagnostic procedures compared with many colonoscopy studies. 548 GASTROINTESTINAL ENDOSCOPY Volume 71, No. 3 :

8 DeMarco et al Impact of experience with a retrograde-viewing device on adenoma detection rates during colonoscopy Limitations of the study included the lack of randomization or blinding and the lack of a separate control group. Determinations regarding adequacy of bowel cleansing and whether each polyp could have been detected with the colonoscope alone involved a judgment by the endoscopist. However, to prevent an unfair advantage for the TER, polyp detection was biased toward the colonoscope. Increased cleansing during intubation likely enhanced detection by the colonoscope before the TER was inserted, and the endoscopists were instructed to remove such lesions immediately. If a polyp was found with both the colonoscope and TER, it was counted as detection with the colonoscope. Especially before they gained experience in observing both sides of the split-screen video display, some endoscopists might have focused more on the novel TER image on the right side of the screen, resulting in failure to detect some lesions in the colonoscope view on the left side of the screen. However, such an effect would be expected to exaggerate the additional detection rate for TER in the earlier quartiles more so than in the later quartiles, and that would be counter to the trend shown in the study results. Also, observation of multiple views has not adversely affected endoscopy efficacy in other gastroenterological modalities such as capsule endoscopy. 30 CONCLUSIONS Experienced endoscopists new to the TER were able to detect a mean of 15.4% additional adenomas during their first 5 procedures. After completing at least 15 procedures with the device, their mean additional detection rates with the TER compared with the colonoscope alone were 17.0% for all polyps and 25.0% for adenomas of all sizes. Additional detection rates with the TER for medium-size and large adenomas were greater than those for smaller lesions. Procedure times did not vary significantly as more procedures were performed. These results suggest that, compared with routine colonoscopy, a retrograde-viewing device can increase detection rates for clinically significant adenomas without detriment to procedure time or procedure complications. REFERENCES 1. Jemal A, Siegel R, Ward E, et al. Cancer Statistics, Ca Cancer J Clin 2009;59: Rex DK, Bond JH, Winawer S, et al. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2002;97: U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;149: Rex DK, Johnson DA, Inadomi JM, et al. American College of Gastroenterology guidelines for colorectal cancer screening Am J Gastroenterol 2009;104: Levin B, Lieberman DA, Winawer SJ, et al. American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008;58: Winawer SJ, Zauber AG, Rex DK, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi- Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 2006;130: Hixson LJ, Fennerty MB, Sampliner RE, et al. Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. Gastrointest Endosc 1991;37: Rex DK, Cutler CS, Mark DG, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997; 112: Van Rijn JC, Reitsma JB, Dekker E, et al. Polyp miss rate determined by tandem colonoscopy: a systemic review. Am J Gastroenterol 2006;101: Heresbach D, Barrioz T, Ponchon T, et al. Miss rate for colorectal neoplastic polyps: a prospective multicenter study of back-to-back video colonoscopies. Endoscopy 2008;40: Soetikno RM, Kaltenbach T, Friedland S, et al. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA 2008;299: Van Gelder RE, Nio CY, Stoker J, et al. Computed tomographic colonography compared with colonoscopy in patients at increased risk for colorectal cancer. Gastroenterology 2004;127: Pickhardt PJ, Nugent PA, Schindler WR, et al. Location of adenomas missed by optical colonoscopy. Ann Intern Med 2004;141: Pabby A, Schoen RE, Schatzkin A, et al. Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial. Gastrointest Endosc 2005;61: Postic G, Lewin D, Wallace MB, et al. Colonoscopic miss rates determined by direct comparison of colonoscopy with colon resection specimens. Am J Gastroenterol 2002;97: Bressler B, Paszat LF, Rabeneck L, et al. Colonoscopic miss rates for rightsided colon cancer: a population-based analysis. Gastroenterology 2004;127: Triadafilopoulos G, Watts HD, Van Dam J, et al. A novel retrogradeviewing auxiliary imaging device (Third Eye Retroscope) improves the detection of simulated polyps in anatomic models of the colon. Gastrointest Endosc 2007;65: Triadafilopoulos G, Li J. A pilot study to assess the safety and efficacy of the Third Eye retrograde auxiliary imaging system during colonoscopy. Endoscopy 2008;40: Waye JD, Russell IH, Fleischer DE, et al. A retrograde-viewing device improves detection of adenomas in the colon: a prospective efficacy evaluation (with videos). Gastrointest Endosc 2010;71: Rostom A, Jolicoeur E. Validation of a new scale for the assessment of bowel preparation quality. Gastrointest Endosc 2004;59: Harewood GC, Sharma VK, de Garmo P. Impact of colonoscopy preparation quality on detection of suspected colonic neoplasia. Gastrointest Endosc 2003;58: Froehlich F, Wietlisbach V, Vader JP, et al. Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: the European Panel of Appropriateness of Gastrointestinal Endoscopy European multicenter study. Gastrointest Endosc 2005;61: Rex DK. Colonoscopic withdrawal technique is associated with adenoma miss rates. Gastrointest Endosc 2000;51: Barclay RL, Vicari JJ, Doughty AS, et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med 2006;355: Sanchez W, Harewood GC, Petersen BT. Evaluation of polyp detection in relation to procedure time of screening or surveillance colonoscopy. Am J Gastroenterol 2004;99: Volume 71, No. 3 : 2010 GASTROINTESTINAL ENDOSCOPY 549

9 Impact of experience with a retrograde-viewing device on adenoma detection rates during colonoscopy DeMarco et al 26. Simmons DT, Harewood GC, Baron TH, et al. Impact of endoscopist withdrawal speed on polyp yield: implications for optimal colonoscopy withdrawal time. Aliment Pharmacol Ther 2006;24: Schatzkin A, Lanza E, Corle D, et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. N Engl J Med 2000;342: Lieberman DA, WeissDG, BondJH, etal. Useofcolonoscopytoscreenasymptomatic adults for colorectal cancer. N Engl J Med 2000;343: Rex DK. Maximizing detection of adenomas and cancers during colonoscopy. Am J Gastroenterol 2006;101: Westerhof J, Koornstra JJ, Weersma RK. Can we reduce capsule endoscopy reading times? Gastrointest Endosc 2009;69: GIE on Facebook GIE now has a Facebook page. Fans will receive news, updates, and links to author interviews, podcasts, articles, and tables of contents. Search on Facebook for GIE: Gastrointestinal Endoscopy and become a fan. 550 GASTROINTESTINAL ENDOSCOPY Volume 71, No. 3 :

Retroflexion and prevention of right-sided colon cancer following colonoscopy: How I approach it

Retroflexion and prevention of right-sided colon cancer following colonoscopy: How I approach it Retroflexion and prevention of right-sided colon cancer following colonoscopy: How I approach it Douglas K Rex 1 MD, MACG 1. Indiana University School of Medicine Division of Gastroenterology/Hepatology

More information

Variation in Detection of Adenomas and Polyps by Colonoscopy and Change Over Time With a Performance Improvement Program

Variation in Detection of Adenomas and Polyps by Colonoscopy and Change Over Time With a Performance Improvement Program CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2009;7:1335 1340 Variation in Detection of Adenomas and Polyps by Colonoscopy and Change Over Time With a Performance Improvement Program AASMA SHAUKAT,*, CRISTINA

More information

Devices To Improve Colon Polyp Detection

Devices To Improve Colon Polyp Detection Devices To Improve Colon Polyp Detection ACG/VGS Regional Postgraduate Course Sep 10-11, 2016 Williamsburg, VA VIVEK KAUL, MD, FACG Segal-Watson Professor of Medicine Chief, Division of Gastroenterology

More information

Colorectal cancer is the second leading cause of cancer-related. Colonoscopic Miss Rates for Right-Sided Colon Cancer: A Population-Based Analysis

Colorectal cancer is the second leading cause of cancer-related. Colonoscopic Miss Rates for Right-Sided Colon Cancer: A Population-Based Analysis GASTROENTEROLOGY 2004;127:452 456 Colonoscopic Miss Rates for Right-Sided Colon Cancer: A Population-Based Analysis BRIAN BRESSLER,* LAWRENCE F. PASZAT,, CHRISTOPHER VINDEN,, CINDY LI, JINGSONG HE, and

More information

Alberta Colorectal Cancer Screening Program (ACRCSP) Post Polypectomy Surveillance Guidelines

Alberta Colorectal Cancer Screening Program (ACRCSP) Post Polypectomy Surveillance Guidelines Alberta Colorectal Cancer Screening Program (ACRCSP) Post Polypectomy Surveillance Guidelines June 2013 ACRCSP Post Polypectomy Surveillance Guidelines - 2 TABLE OF CONTENTS Background... 3 Terms, Definitions

More information

Colorectal Cancer Screening

Colorectal Cancer Screening Recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer Colorectal Cancer Screening Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Levin TR, Lieberman D, Robertson

More information

Benchmarking For Colonoscopy. Technology and Technique to Improve Adenoma Detection

Benchmarking For Colonoscopy. Technology and Technique to Improve Adenoma Detection Benchmarking For Colonoscopy Technology and Technique to Improve Adenoma Detection Objectives 1. Review the latest data on performance characteristics and efficacy for colon cancer prevention 2. Highlight

More information

Quality Indicators in Colonoscopy

Quality Indicators in Colonoscopy Symposium Symposium III - Lower GI : Quality Colonoscopy Quality Indicators in Colonoscopy Kyu Chan Huh Department of Internal medicine, Konyang University College of Medicine, Daejeon, Korea Introduction

More information

Expanding the view of a standard colonoscope with the Third Eye Panoramic cap

Expanding the view of a standard colonoscope with the Third Eye Panoramic cap Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v21.i37.10683 World J Gastroenterol 2015 October 7; 21(37): 10683-10687 ISSN 1007-9327

More information

Circumstances in which colonoscopy misses cancer

Circumstances in which colonoscopy misses cancer 1 Department of Medicine, University of Toronto, Toronto, Canada 2 Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada 3 The Dalla Lana School of Public Health,

More information

Title Description Type / Priority

Title Description Type / Priority Merit-based Incentive Payment system (MIPS) 2019 Qualified Clinical Data Registry (QCDR) Measure Specifications Summary Listing of QCDR measures supported by the NHCR Measure # NHCR4 NHCR5 GIQIC12 GIQIC15

More information

Digestive Health Southwest Endoscopy 2016 Quality Report

Digestive Health Southwest Endoscopy 2016 Quality Report Digestive Health 2016 Quality Report Our 2016 our quality and value management program focused on one primary area of interest: Performing high quality colonoscopy High quality Colonoscopy We selected

More information

GI Quality Improvement Consortium, Ltd. (GIQuIC) QCDR Non-PQRS Measure Specifications

GI Quality Improvement Consortium, Ltd. (GIQuIC) QCDR Non-PQRS Measure Specifications GI Quality Improvement Consortium, Ltd. (GIQuIC) 1 Following is an overview of the clinical quality measures in GIQuIC that can be reported to CMS for the Physician Quality Report System (PQRS) via GIQuIC

More information

GIQIC18 Appropriate follow-up interval of not less than 5 years for colonoscopies with findings of 1-2 tubular adenomas < 10 mm

GIQIC18 Appropriate follow-up interval of not less than 5 years for colonoscopies with findings of 1-2 tubular adenomas < 10 mm GI Quality Improvement Consortium, Ltd. (GIQuIC) 1 Following is an overview of the clinical quality measures in GIQuIC that can be reported to CMS for the Quality performance category of the Merit-Based

More information

Choice of sedation and its impact on adenoma detection rate in screening colonoscopies

Choice of sedation and its impact on adenoma detection rate in screening colonoscopies ORIGINAL ARTICLE Annals of Gastroenterology (2016) 29, 1-6 Choice of sedation and its impact on adenoma detection rate in screening colonoscopies Rahman Nakshabendi a, Andrew C. Berry b, Juan C. Munoz

More information

Colon Polyps: Detection, Inspection and Characteristics

Colon Polyps: Detection, Inspection and Characteristics Colon Polyps: Detection, Inspection and Characteristics Stephen Kim, M.D. Assistant Professor of Medicine Interventional Endoscopy Services UCLA Division of Digestive Diseases September 29, 2018 1 Disclosures

More information

Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care

Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION: The

More information

Colorectal Cancer Screening: A Clinical Update

Colorectal Cancer Screening: A Clinical Update 11:05 11:45am Colorectal Cancer Screening: A Clinical Update SPEAKER Kevin A. Ghassemi, MD Presenter Disclosure Information The following relationships exist related to this presentation: Kevin A. Ghassemi,

More information

Prof Rupert Leong, Director of Endoscopy, Head of IBD Professor of Medicine UNSW, University of Sydney, Concord Hospital Australia IBDSydney

Prof Rupert Leong, Director of Endoscopy, Head of IBD Professor of Medicine UNSW, University of Sydney, Concord Hospital Australia IBDSydney 10:30-10:50 25 Sept 2017 Monday A-PSDE / WEO Colorectal Cancer Screening Committee (CRCSC) Meeting Room S228 (2/F) Prof Rupert Leong, Director of Endoscopy, Head of IBD Professor of Medicine UNSW, University

More information

When a patient develops colorectal cancer within a few

When a patient develops colorectal cancer within a few CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2013;11:768 773 Avoiding and Defending Malpractice Suits for Postcolonoscopy Cancer: Advice From an Expert Witness DOUGLAS K. REX Division of Gastroenterology/Hepatology,

More information

Technology and Interventions to Improve ADR

Technology and Interventions to Improve ADR Technology and Interventions to Improve ADR Aasma Shaukat, MD MPH, FACG GI Section Chief, Minneapolis VAMC Associate Professor, University of Minnesota Outline Why is quality important? Fundamentals of

More information

Multicenter, randomized, tandem evaluation of EndoRings colonoscopy results of the CLEVER study

Multicenter, randomized, tandem evaluation of EndoRings colonoscopy results of the CLEVER study Multicenter, randomized, tandem evaluation of EndoRings colonoscopy results of the CLEVER study Authors Institutions Vincent K. Dik 1, Ian M. Gralnek 2, 3,4, Ori Segol 3,5, Alain Suissa 3, 6, Tim D. G.

More information

C olorectal adenomas are reputed to be precancerous

C olorectal adenomas are reputed to be precancerous 568 COLORECTAL CANCER Incidence and recurrence rates of colorectal adenomas estimated by annually repeated colonoscopies on asymptomatic Japanese Y Yamaji, T Mitsushima, H Ikuma, H Watabe, M Okamoto, T

More information

The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research

The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research ORIGINAL ARTICLE: Clinical Endoscopy The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research Edwin J. Lai, MD, Audrey H. Calderwood, MD, Gheorghe Doros, PhD,

More information

Colorectal Cancer Screening: Colonoscopy, Potential and Pitfalls. Disclosures: None. CRC: still a major public health problem

Colorectal Cancer Screening: Colonoscopy, Potential and Pitfalls. Disclosures: None. CRC: still a major public health problem Colorectal Cancer Screening: Colonoscopy, Potential and Pitfalls Disclosures: None Jonathan P. Terdiman, M.D. Professor of Clinical Medicine University of California, San Francisco CRC: still a major public

More information

CRC Risk Factors. U.S. Adherence Rates Cancer Screening. Genetic Model of Colorectal Cancer. Epidemiology and Clinical Consequences of CRC

CRC Risk Factors. U.S. Adherence Rates Cancer Screening. Genetic Model of Colorectal Cancer. Epidemiology and Clinical Consequences of CRC 10:45 11:45 am Guide to Colorectal Cancer Screening SPEAKER Howard Manten M.D. Presenter Disclosure Information The following relationships exist related to this presentation: Howard Manten MD: No financial

More information

General and Colonoscopy Data Collection Form

General and Colonoscopy Data Collection Form Identifier: Sociodemographic Information Type: Zip Code: Inpatient Outpatient Birth Date: m m d d y y y y Gender: Height: (inches) Male Female Ethnicity: Weight: (pounds) African American White, Non-Hispanic

More information

Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care

Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: The rate of screening

More information

Improving the quality of endoscopic polypectomy by introducing a colonoscopy quality assurance program

Improving the quality of endoscopic polypectomy by introducing a colonoscopy quality assurance program Alexandria Journal of Medicine (13) 49, 317 322 Alexandria University Faculty of Medicine Alexandria Journal of Medicine www.sciencedirect.com ORIGINAL ARTICLE Improving the quality of endoscopic polypectomy

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Kaminski MF, Regula J, Kraszewska E, et al. Quality indicators

More information

August 21, National Quality Forum th St, NW Suite 800 Washington, D.C Re: Colonoscopy Quality Index (NQF# C 2056)

August 21, National Quality Forum th St, NW Suite 800 Washington, D.C Re: Colonoscopy Quality Index (NQF# C 2056) August 21, 2012 National Quality Forum 1030 15th St, NW Suite 800 Washington, D.C. 20005 Re: Colonoscopy Quality Index (NQF# C 2056) The American College of Gastroenterology (ACG), American Gastroenterological

More information

Colonoscopy is the preferred procedure for the investigation of large bowel and

Colonoscopy is the preferred procedure for the investigation of large bowel and Original Article Comparison of two different methods of colon cleansing for afternoon-colonoscopy Kobra Baghbani (MD) 1 Javad Shokry-Shirvani (MD) * 1 Hassan Taheri (MD) 1 1. Department of Internal Medicine,

More information

Colonoscopy MM /01/2010. PPO; HMO; QUEST Integration 10/01/2017 Section: Surgery Place(s) of Service: Outpatient

Colonoscopy MM /01/2010. PPO; HMO; QUEST Integration 10/01/2017 Section: Surgery Place(s) of Service: Outpatient Colonoscopy Policy Number: Original Effective Date: MM.12.003 12/01/2010 Line(s) of Business: Current Effective Date: PPO; HMO; QUEST Integration 10/01/2017 Section: Surgery Place(s) of Service: Outpatient

More information

Colonoscopic Withdrawal Times and Adenoma Detection during Screening Colonoscopy

Colonoscopic Withdrawal Times and Adenoma Detection during Screening Colonoscopy original article Colonoscopic Withdrawal Times and Adenoma Detection during Screening Colonoscopy Robert L. Barclay, M.D., Joseph J. Vicari, M.D., Andrea S. Doughty, Ph.D., John F. Johanson, M.D., and

More information

Guidelines for Colonoscopy Surveillance After Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer

Guidelines for Colonoscopy Surveillance After Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer Guidelines for Colonoscopy Surveillance After Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer David A. Lieberman, 1 Douglas K. Rex, 2 Sidney J. Winawer,

More information

Interval Cancers: What is Next?

Interval Cancers: What is Next? Interval Cancers: What is Next? Douglas Corley, MD, PhD Kaiser Permanente, Northern California Gastroenterologist, TPMG Director of Delivery Science & Applied Research Defining the mission Mercury project:

More information

Quality Measures In Colonoscopy: Why Should I Care?

Quality Measures In Colonoscopy: Why Should I Care? Quality Measures In Colonoscopy: Why Should I Care? David Greenwald, MD, FASGE Professor of Clinical Medicine Albert Einstein College of Medicine Montefiore Medical Center Bronx, New York ACG/ASGE Best

More information

Improving you ADR. Robert Enns Colonoscopy Education Day October 2018

Improving you ADR. Robert Enns Colonoscopy Education Day October 2018 Improving you ADR Robert Enns Colonoscopy Education Day October 2018 ADR Applying to CSP Assume 50% ADR in FIT positive patients Out of 40 patients only 20 will have polyps Out of 20 likely 15 will be

More information

Quality in Endoscopy: Can We Do Better?

Quality in Endoscopy: Can We Do Better? Quality in Endoscopy: Can We Do Better? Erik Rahimi, MD Assistant Professor Division of Gastroenterology, Hepatology, and Nutrition UT Health Science Center at Houston McGovern Medical School Ertan Digestive

More information

Spartan Medical Research Journal

Spartan Medical Research Journal Spartan Medical Research Journal Research at Michigan State University College of Osteopathic Medicine Volume 2 Number 2 Winter, 2017 Pages 14-21 Title: Endoscopic Combined Snare-Forceps Technique for

More information

Optical colonoscopy (OC) is widely accepted as the

Optical colonoscopy (OC) is widely accepted as the Article Location of Adenomas Missed by Optical Colonoscopy Perry J. Pickhardt, MD; Pamela A. Nugent, MD; Pauline A. Mysliwiec, MD, MPH; J. Richard Choi, ScD, MD; and William R. Schindler, DO Background:

More information

EXPERT WORKING GROUP Surveillance after neoplasia removal. Meeting Chicago, May 5th 2017 Chair: Rodrigo Jover Uri Ladabaum

EXPERT WORKING GROUP Surveillance after neoplasia removal. Meeting Chicago, May 5th 2017 Chair: Rodrigo Jover Uri Ladabaum EXPERT WORKING GROUP Surveillance after neoplasia removal Meeting Chicago, May 5th 2017 Chair: Rodrigo Jover Uri Ladabaum AIM To improve the quality of the evidences we have regarding post- polypectomy

More information

Early detection and screening for colorectal neoplasia

Early detection and screening for colorectal neoplasia Early detection and screening for colorectal neoplasia Robert S. Bresalier Department of Gastroenterology, Hepatology and Nutrition. The University of Texas. MD Anderson Cancer Center. Houston, Texas U.S.A.

More information

Tips to Improve ADRs during Colonoscopy

Tips to Improve ADRs during Colonoscopy Tips to Improve ADRs during Colonoscopy Aasma Shaukat, MD, MPH, FACG GI Section Chief, Minneapolis VAMC Associate Professor, University of Minnesota Outline Why is quality important? Fundamentals of high-quality

More information

Romanian Journal of Morphology and Embryology 2006, 47(3):

Romanian Journal of Morphology and Embryology 2006, 47(3): Romanian Journal of Morphology and Embryology 26, 7(3):239 23 ORIGINAL PAPER Predictive parameters for advanced neoplastic adenomas and colorectal cancer in patients with colonic polyps a study in a tertiary

More information

This is the portion of the intestine which lies between the small intestine and the outlet (Anus).

This is the portion of the intestine which lies between the small intestine and the outlet (Anus). THE COLON This is the portion of the intestine which lies between the small intestine and the outlet (Anus). 3 4 5 This part is responsible for formation of stool. The large intestine (colon- coloured

More information

Summary. Cezary ŁozińskiABDF, Witold KyclerABCDEF. Rep Pract Oncol Radiother, 2007; 12(4):

Summary. Cezary ŁozińskiABDF, Witold KyclerABCDEF. Rep Pract Oncol Radiother, 2007; 12(4): Rep Pract Oncol Radiother, 2007; 12(4): 201-206 Original Paper Received: 2006.12.19 Accepted: 2007.04.02 Published: 2007.08.31 Authors Contribution: A Study Design B Data Collection C Statistical Analysis

More information

THE BIG, AWKWARD, FLAT POLYP THAT CAN T BE REMOVED WITH A (SINGLE) SNARE THE CASE FOR EMR AND ESD

THE BIG, AWKWARD, FLAT POLYP THAT CAN T BE REMOVED WITH A (SINGLE) SNARE THE CASE FOR EMR AND ESD THE BIG, AWKWARD, FLAT POLYP THAT CAN T BE REMOVED WITH A (SINGLE) SNARE THE CASE FOR EMR AND ESD Surgical Oncology Network meeting Dr. Eric Lam MD FRCPC October 14, 2017 DISCLOSURES None OBJECTIVES Appreciate

More information

UvA-DARE (Digital Academic Repository) Serrated polyps of the colon and rectum Hazewinkel, Y. Link to publication

UvA-DARE (Digital Academic Repository) Serrated polyps of the colon and rectum Hazewinkel, Y. Link to publication UvA-DARE (Digital Academic Repository) Serrated polyps of the colon and rectum Hazewinkel, Y. Link to publication Citation for published version (APA): Hazewinkel, Y. (2014). Serrated polyps of the colon

More information

Citation for published version (APA): Wijkerslooth de Weerdesteyn, T. R. (2013). Population screening for colorectal cancer by colonoscopy

Citation for published version (APA): Wijkerslooth de Weerdesteyn, T. R. (2013). Population screening for colorectal cancer by colonoscopy UvA-DARE (Digital Academic Repository) Population screening for colorectal cancer by colonoscopy de Wijkerslooth, T.R. Link to publication Citation for published version (APA): Wijkerslooth de Weerdesteyn,

More information

Merit-based Incentive Payment system (MIPS) 2018 Qualified Clinical Data Registry (QCDR) Measure Specifications

Merit-based Incentive Payment system (MIPS) 2018 Qualified Clinical Data Registry (QCDR) Measure Specifications Merit-based Incentive Payment system (MIPS) 2018 Qualified Clinical Data Registry (QCDR) Measure Specifications This document contains a listing of the clinical quality measures which the New Hampshire

More information

Polyps Adenomas Lipomas

Polyps Adenomas Lipomas 30 Chapter 2 CT Colonography Chapter 2 Polyps Adenomas Lipomas Case 8 Case 9 Case 10 Case 11 Case 12 Case 13 Case 14 Case 15 Case 16 Case 17 Case 18 Pseudopolyp Polyp after intravenous administration of

More information

Colon Cancer Detection by Rendezvous Colonoscopy : Successful Removal of Stuck Colon Capsule by Conventional Colonoscopy

Colon Cancer Detection by Rendezvous Colonoscopy : Successful Removal of Stuck Colon Capsule by Conventional Colonoscopy 19 Colon Cancer Detection by Rendezvous Colonoscopy : Successful Removal of Stuck Colon Capsule by Conventional Colonoscopy István Rácz Márta Jánoki Hussam Saleh Department of Gastroenterology, Petz Aladár

More information

Combination of Sigmoidoscopy and a Fecal Immunochemical Test to Detect Proximal Colon Neoplasia

Combination of Sigmoidoscopy and a Fecal Immunochemical Test to Detect Proximal Colon Neoplasia CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2009;7:1341 1346 Combination of Sigmoidoscopy and a Fecal Immunochemical Test to Detect Proximal Colon Neoplasia JUN KATO,* TAMIYA MORIKAWA,* MOTOAKI KURIYAMA,*

More information

Finding and Removing Difficult Polyps (safely)

Finding and Removing Difficult Polyps (safely) Finding and Removing Difficult Polyps (safely) David Lieberman MD Chief, Division of Gastroenterology and Hepatology Oregon Health and Science University Colonoscopy Clouds Interval Cancers Interval Cancer:

More information

Measuring the quality of colonoscopy: Where are we now and where are we going?

Measuring the quality of colonoscopy: Where are we now and where are we going? Measuring the quality of colonoscopy: Where are we now and where are we going? Timothy D. Imler, MD Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana

More information

Joint Session with ACOFP and Cancer Treatment Centers of America (CTCA): Cancer Screening: Consensus & Controversies. Ashish Sangal, M.D.

Joint Session with ACOFP and Cancer Treatment Centers of America (CTCA): Cancer Screening: Consensus & Controversies. Ashish Sangal, M.D. Joint Session with ACOFP and Cancer Treatment Centers of America (CTCA): Cancer Screening: Consensus & Controversies Ashish Sangal, M.D. Cancer Screening: Consensus & Controversies Ashish Sangal, MD Director,

More information

Missed Lesions at Endoscopy. Dr Russell Walmsley, MD, FRCP, FRACP Gastroenterologist WDHB Chair Endoscopy Guidance Group for New Zealand

Missed Lesions at Endoscopy. Dr Russell Walmsley, MD, FRCP, FRACP Gastroenterologist WDHB Chair Endoscopy Guidance Group for New Zealand Missed Lesions at Endoscopy Dr Russell Walmsley, MD, FRCP, FRACP Gastroenterologist WDHB Chair Endoscopy Guidance Group for New Zealand Missed Lesions at Endoscopy Is there a problem? With Gastroscopy

More information

Colorectal Cancer Prevention Quantity and Quality Count

Colorectal Cancer Prevention Quantity and Quality Count Colorectal Cancer Prevention Quantity and Quality Count Ernesto Drelichman, MD Gastrointestinal Surgery & Endoscopy Providence Hospital Key Messages Colorectal cancer can be prevented Screening reduces

More information

Efficacy of Endocuff-assisted colonoscopy in the detection of colorectal polyps

Efficacy of Endocuff-assisted colonoscopy in the detection of colorectal polyps Efficacy of Endocuff-assisted colonoscopy in the detection of colorectal polyps Authors Yoshiki Wada 1,2, Masayoshi Fukuda 2, Kazuo Ohtsuka 2, Mamoru Watanabe 3, Yumiko Fukuma 1,YokoWada 1, Masahiro Wada

More information

Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative

Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative Name: Institution: Michal F. Kaminski, MD, PhD Dept. of

More information

Latest Endoscopic Guidelines for FAP, HNPCC, IBD, and the General Population

Latest Endoscopic Guidelines for FAP, HNPCC, IBD, and the General Population Latest Endoscopic Guidelines for FAP, HNPCC, IBD, and the General Population David T. Rubin, M.D. Assistant Professor of Medicine Inflammatory Bowel Disease Center MacLean Center for Clinical Medical Ethics

More information

THE INS & OUTS OF COLONOSCOPY

THE INS & OUTS OF COLONOSCOPY THE INS & OUTS OF COLONOSCOPY INSERTION TIPS & FEATURES OF HIGH-QUALITY WITHDRAWAL C A M E R O N B E L L R O Y A L N O R T H S H O R E H O S P I T A L C H A I R, N E T I N A T I O N A L T C T L E A D WHY

More information

But.. Capsule Endoscopy. Guidelines (OMED ECCO) Why is Enteroscopy so Important? 4/19/2017

But.. Capsule Endoscopy. Guidelines (OMED ECCO) Why is Enteroscopy so Important? 4/19/2017 Dr. Elizabeth Odstrcil Digestive Health Associates of Texas April 22, 2017 But.. Capsules fail to reach the cecum in as many as 25% of patients Patients with known CD have a risk of capsule retention of

More information

Repeat colonoscopy s value in gastrointestinal bleeding

Repeat colonoscopy s value in gastrointestinal bleeding Online Submissions: http://www.wjgnet.com/esps/ wjge@wjgnet.com doi:10.4253/wjge.v5.i2.56 World J Gastrointest Endosc 2013 February 16; 5(2): 56-61 ISSN 1948-5190 (online) 2013 Baishideng. All rights reserved.

More information

A randomised tandem colonoscopy trial of narrow band imaging versus white light examination to compare neoplasia miss rates

A randomised tandem colonoscopy trial of narrow band imaging versus white light examination to compare neoplasia miss rates VA Palo Alto HCS, Stanford University School of Medicine, Palo Alto, CA, USA Correspondence to: Dr R Soetikno, VA Palo Alto Health Care System, Stanford University School of Medicine, 3801 Miranda Ave,

More information

Tumor Localization for Laparoscopic Colorectal Surgery

Tumor Localization for Laparoscopic Colorectal Surgery World J Surg (2007) 31:1491 1495 DOI 10.1007/s00268-007-9082-7 Tumor Localization for Laparoscopic Colorectal Surgery Yong Beom Cho Æ Woo Yong Lee Æ Hae Ran Yun Æ Won Suk Lee Æ Seong Hyeon Yun Æ Ho-Kyung

More information

Colorectal cancer (CRC) is a serious health problem

Colorectal cancer (CRC) is a serious health problem Impact of Wide-Angle, High-Definition Endoscopy in the Diagnosis of Colorectal Neoplasia: A Randomized Controlled Trial MARIA PELLISÉ, GLÒRIA FERNÁNDEZ ESPARRACH, ANDRÉS CÁRDENAS, ORIOL SENDINO, ELENA

More information

COLON: Innovations 3 steps, 3 parts..

COLON: Innovations 3 steps, 3 parts.. COLON: Innovations 3 steps, 3 parts.. Detection: I see an abnormality (usually a polyp) Characterization: Is this abnormality neoplastic? (for example: an adenoma) Treatment: it is neoplastic. Can I treat

More information

removal of adenomatous polyps detects important effectively as follow-up colonoscopy after both constitute a low-risk Patients with 1 or 2

removal of adenomatous polyps detects important effectively as follow-up colonoscopy after both constitute a low-risk Patients with 1 or 2 Supplementary Table 1. Study Characteristics Author, yr Design Winawer et al., 6 1993 National Polyp Study Jorgensen et al., 9 1995 Funen Adenoma Follow-up Study USA Multi-center, RCT for timing of surveillance

More information

ALIMENTARY TRACT FIBEROPTIC PANSIGMOIDOSCOPY. An evaluation and comparison with rigid sigmoidoscopy

ALIMENTARY TRACT FIBEROPTIC PANSIGMOIDOSCOPY. An evaluation and comparison with rigid sigmoidoscopy GASTROENTEROLOGY 72:644-649, 1977 Copyright 1977 by The American Gastroenterological Association Vol. 72, No.4, Part 1 Printed in U.S.A. ALIMENTARY TRACT FIBEROPTIC PANSIGMOIDOSCOPY An evaluation and comparison

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Virtual Colonoscopy / CT Colonography Page 1 of 19 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Virtual Colonoscopy / CT Colonography Professional Institutional

More information

DIGESTIVE SYSTEM SURGICAL PROCEDURES May 1, 2015 INTESTINES (EXCEPT RECTUM) Asst Surg Anae

DIGESTIVE SYSTEM SURGICAL PROCEDURES May 1, 2015 INTESTINES (EXCEPT RECTUM) Asst Surg Anae ENDOSCOPY Z50 Duodenoscopy (not to be claimed if Z399 and/or Z00 performed on same patient within 3 months)... 92.10 Z9 Subsequent procedure (within three months following previous endoscopic procedure)...

More information

Colonoscopy Quality Data

Colonoscopy Quality Data Colonoscopy Quality Data www.dhsgi.com Introduction Colorectal cancer is the second leading cause of cancer related deaths in the United States, in men and women combined. In 2016, there are expected to

More information

Supporting Information 2. ESGE QIC Lower GI Delphi voting process: Round 1 Working Group chair: Michal F. Kaminski, Poland

Supporting Information 2. ESGE QIC Lower GI Delphi voting process: Round 1 Working Group chair: Michal F. Kaminski, Poland Supporting Information 2. ESGE QIC Lower GI Delphi voting process: Round 1 Working chair: Michal F. Kaminski, Poland Population Interventions Comparator Outcome Additional evidence 1.1 Rate of adequate

More information

Incidence and Multiplicities of Adenomatous Polyps in TNM Stage I Colorectal Cancer in Korea

Incidence and Multiplicities of Adenomatous Polyps in TNM Stage I Colorectal Cancer in Korea Original Article Journal of the Korean Society of J Korean Soc Coloproctol 2012;28(4):213-218 http://dx.doi.org/10.3393/jksc.2012.28.4.213 pissn 2093-7822 eissn 2093-7830 Incidence and Multiplicities of

More information

Kenneth D. Chi, MD Medical Director, GI Lab Advocate Lutheran General Hospital Center for Digestive Health May 7, 2016

Kenneth D. Chi, MD Medical Director, GI Lab Advocate Lutheran General Hospital Center for Digestive Health May 7, 2016 Kenneth D. Chi, MD Medical Director, GI Lab Advocate Lutheran General Hospital Center for Digestive Health May 7, 2016 Why have Quality Indicators? Pre-procedure Quality Indicators Intra-procedure Quality

More information

PROCESS. These recommendations were developed by members of the National Colorectal Cancer Roundtable, a coalition of nearly 60

PROCESS. These recommendations were developed by members of the National Colorectal Cancer Roundtable, a coalition of nearly 60 The Quality of Colonoscopy Services Responsibilities of Referring Clinicians A Consensus Statement of the Quality Assurance Task Group, National Colorectal Cancer Roundtable Robert H. Fletcher, MD, MSc

More information

COLON CANCER SCREENING: AN UPDATE

COLON CANCER SCREENING: AN UPDATE Overview COLON CANCER SCREENING: AN UPDATE Siddharth Verma, DO, JD Rutgers New Jersey Medical School Background Screening Updates in Specific Populations African Americans CRC in the younger age USPSTF

More information

Colorectal Cancer Screening: Cost-Effectiveness and Adverse events October, 2005

Colorectal Cancer Screening: Cost-Effectiveness and Adverse events October, 2005 Colorectal Cancer Screening: Cost-Effectiveness and Adverse events October, 2005 David Lieberman MD Chief, Division of Gastroenterology Oregon Health and Science University Portland VAMC Portland, Oregon

More information

The Canadian Cancer Society estimates that in

The Canadian Cancer Society estimates that in How Do I Screen For Colorectal Cancer? By Ted M. Ross, MD, FRCS(C); and Naomi Ross, RD, BSc To be presented at the University of Toronto s Primary Care Today sessions (October 3, 2003) The Canadian Cancer

More information

Endocuff assisted colonoscopy significantly increases sessile serrated adenoma detection in veterans

Endocuff assisted colonoscopy significantly increases sessile serrated adenoma detection in veterans Original Article Endocuff assisted colonoscopy significantly increases sessile serrated adenoma detection in veterans Michael D. Baek 1,2, Christian S. Jackson 2, John Lunn 2, Chris Nguyen 1,2, Nicole

More information

HIGH-DEFINITION (HD) COLONOSCOPE, which

HIGH-DEFINITION (HD) COLONOSCOPE, which Digestive Endoscopy 2015; 27 (Suppl. 1): 40 44 doi: 10.1111/den.12428 Screening colonoscopy: What is the most reliable modality for colorectal lesion s characterization? Advanced technology for the improvement

More information

How to characterize dysplastic lesions in IBD?

How to characterize dysplastic lesions in IBD? How to characterize dysplastic lesions in IBD? Name: Institution: Helmut Neumann, MD, PhD, FASGE University Medical Center Mainz What do we know? Patients with IBD carry an increased risk of developing

More information

Colonoscopic Screening of Average-Risk Women for Colorectal Neoplasia

Colonoscopic Screening of Average-Risk Women for Colorectal Neoplasia The new england journal of medicine original article Colonoscopic Screening of Average-Risk Women for Colorectal Neoplasia Philip Schoenfeld, M.D., Brooks Cash, M.D., Andrew Flood, Ph.D., Richard Dobhan,

More information

Variable Endoscopist performance in proximal and distal adenoma detection during colonoscopy: a retrospective cohort study

Variable Endoscopist performance in proximal and distal adenoma detection during colonoscopy: a retrospective cohort study James et al. BMC Gastroenterology (2018) 18:73 https://doi.org/10.1186/s12876-018-0800-4 RESEARCH ARTICLE Variable Endoscopist performance in proximal and distal adenoma detection during colonoscopy: a

More information

Journal of. Adenoma Detection on Repeat Colonoscopy after Previous Inadequate Preparation

Journal of. Adenoma Detection on Repeat Colonoscopy after Previous Inadequate Preparation Journal of Gastroenterology and Hepatology Research Online Submissions: http://www.ghrnet.org/index./joghr/ doi:.65/j.issn.4-3.3..37 Journal of GHR 3 December (): -7 ISSN 4-3 (print) ISSN 4-65 (online)

More information

Colonoscopy with polypectomy significantly reduces colorectal

Colonoscopy with polypectomy significantly reduces colorectal CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2009;7:562 567 Utilization and Yield of Surveillance Colonoscopy in the Continued Follow-Up Study of the Polyp Prevention Trial ADEYINKA O. LAIYEMO,*, PAUL F. PINSKY,

More information

Department of Medicine, Hofstra Northwell School of Medicine, Hoftsra University, NY, USA

Department of Medicine, Hofstra Northwell School of Medicine, Hoftsra University, NY, USA Original paper Position change during colonoscopy improves caecal intubation rate, mucosal visibility, and adenoma detection in patients with suboptimal caecal preparation Vijaypal Arya 1,2, Shikha Singh

More information

The Spiral Enteroscopy Experience in 101 Consecutive Patients: Safety and Efficacy Using the Discovery SB

The Spiral Enteroscopy Experience in 101 Consecutive Patients: Safety and Efficacy Using the Discovery SB The Spiral Enteroscopy Experience in 101 Consecutive Patients: Safety and Efficacy Using the Discovery SB Akerman, Paul A. 1 ; Cantero, Daniel 2 ; Avila, Jose 2 ; Pangtay, Jesus 3 ; Agrawal, Deepak 1 Introduction:

More information

Research Article Preliminary Experience Using Full-Spectrum Endoscopy for Colorectal Cancer Screening: Matched Case Controlled Study

Research Article Preliminary Experience Using Full-Spectrum Endoscopy for Colorectal Cancer Screening: Matched Case Controlled Study Gastroenterology Research and Practice Volume 2016, Article ID 1349436, 5 pages http://dx.doi.org/10.1155/2016/1349436 Research Article Preliminary Experience Using Full-Spectrum Endoscopy for Colorectal

More information

Risk Factors for Recurrent High-Risk Polyps after the Removal of High-Risk Polyps at Initial Colonoscopy

Risk Factors for Recurrent High-Risk Polyps after the Removal of High-Risk Polyps at Initial Colonoscopy Original Article Yonsei Med J 2015 Nov;56(6):1559-1565 pissn: 0513-5796 eissn: 1976-2437 Risk Factors for Recurrent High-Risk Polyps after the Removal of High-Risk Polyps at Initial Colonoscopy Hui Won

More information

Research Article Development of Polyps and Cancer in Patients with a Negative Colonoscopy: A Follow-Up Study of More Than 20 Years

Research Article Development of Polyps and Cancer in Patients with a Negative Colonoscopy: A Follow-Up Study of More Than 20 Years ISRN Gastroenterology, Article ID 261302, 4 pages http://dx.doi.org/10.1155/2014/261302 Research Article Development of Polyps and Cancer in Patients with a Negative Colonoscopy: A Follow-Up Study of More

More information

Improving the Adenoma Detection Rate. ADR is a (the) priority quality indicator

Improving the Adenoma Detection Rate. ADR is a (the) priority quality indicator Improving the Adenoma Detection Rate Douglas K. Rex, MD, MACG Indiana University School of Medicine Indianapolis, IN ADR is a (the) priority quality indicator Endorsed Adenoma Detection Rate Cecal intubation

More information

UNDERSTANDING X-RAYS: ABDOMINAL IMAGING THE ABDOMEN

UNDERSTANDING X-RAYS: ABDOMINAL IMAGING THE ABDOMEN UNDERSTANDING X-RAYS: ABDOMINAL IMAGING THE ABDOMEN Radiology Enterprises radiologyenterprises@gmail.com www.radiologyenterprises.com STOMACH AND SMALL BOWEL STOMACH AND SMALL BOWEL Swallowed air is a

More information

Colorectal Cancer Screening and Surveillance

Colorectal Cancer Screening and Surveillance 1 Colorectal Cancer Screening and Surveillance Jeffrey Lee MD, MAS Assistant Clinical Professor of Medicine University of California, San Francisco jeff.lee@ucsf.edu Objectives Review the various colorectal

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Tran AH, Ngor EWM, Wu BU. Surveillance colonoscopy in elderly patients: a retrospective cohort study. JAMA Intern Med. Published online August 11, 2014. doi:10.1001/jamainternmed.2014.3746

More information

ASGE and AGA Issue Consensus Statement on Surveillance and Management of Dysplasia in Patients With Inflammatory Bowel Disease

ASGE and AGA Issue Consensus Statement on Surveillance and Management of Dysplasia in Patients With Inflammatory Bowel Disease ASGE and AGA Issue Consensus Statement on Surveillance and Management of Dysplasia in Patients With Inflammatory Bowel Disease DOWNERS GROVE, Ill., (March 5, 2015) The American Society for Gastrointestinal

More information

Cancer Prevention and Control Program Colloquium series, January 17, 2014 Sudha Xirasagar, MBBS, PhD

Cancer Prevention and Control Program Colloquium series, January 17, 2014 Sudha Xirasagar, MBBS, PhD Cancer Prevention and Control Program Colloquium series, January 17, 2014 Sudha Xirasagar, MBBS, PhD Colorectal Cancer: A tale of WHY NO BEHIND SHOULD BE LEFT BEHIND (Steven Lloyd, 2006) Summary of presentation

More information